Rejuvenation biotechnology: Innovation opportunities for the 21st Century

Thursday 22 April 2021 | 17:00 - 18:00 | Webinar

The pharmaceutical and healthcare industries are undergoing many changes, some of which might bring material shifts to the current landscape. All over the world, people and societies are grappling with the diseases and disabilities of aging. The amount of time, money, and energy already being poured into attempts to thwart diseases like Alzheimer’s, cardiovascular disease, and diabetes is tremendous. Unfortunately, despite progress in treating the symptoms of these diseases, not a single one of them has yet been cured.

As part of innovation month, CFA UK’s Innovation in the Real Economy working group invites Aubrey de Grey to discuss the work of SENS Research Foundation. SENS Research Foundation aims to change the way the world researches and treats age-related disease, pushing the frontiers of medicine by prioritising a regenerative medicine approach to the diseases of aging, and create the initial energy for a true rejuvenation biotechnology industry to develop.

COVID-19's devastating impact on the elderly starkly highlights the enormous benefits to humanity that would be fulfilled by curing the aging problem. The impact of any advancements is not constrained to these industries. It will impact almost all other industries, particularly the investment industry which will need to consider a longer time horizon of its beneficiaries and the changes required in its asset allocation.

This webinar will consider the concepts of healthspan vs lifespan/longevity, gerontology vs geriatrics, to the rejuvenation biotech industry including recent spin-offs and startups.

Where recordings are made, these are a member benefit that are accessed through the member-only platform, CFA UK Discover.


Registration: 16:55

Event: 17:00 - 18:00

CPD points: 1.00


Dr Aubrey de Grey, Chief Science Officer, Strategies for Engineered Negligible Senescence (SENS) Research Foundation

Dr Aubrey de Grey is the biomedical gerontologist who devised the SENS platform, and established SENS Research Foundation to implement it. He received his BA in computer science and Ph.D. in biology from the University of Cambridge in 1985 and 2000, respectively.

Aubrey is Editor-in-Chief of Rejuvenation Research, is a Fellow of both the Gerontological Society of America and the American Aging Association, and sits on the editorial and scientific advisory boards of numerous journals and organisations.

Click here to view our event terms and conditions.